ADB-5'Br-BUTINACA

ADB-5'Br-BUTINACA is a synthetic cannabinoid that is part of the cannabinoid family. It is a designer drug that is often used for recreational purposes. ADB-5'Br-BUTINACA is a potent agonist of the CB1 receptor, which is the primary binding site in the human body for cannabinoids.

Chemistry

ADB-5'Br-BUTINACA is a synthetic cannabinoid that is structurally related to other synthetic cannabinoids such as ADB-FUBINACA and ADB-PINACA. It is a derivative of indazole, with a bromine atom at the 5' position of the butyl side chain. The exact chemical formula of ADB-5'Br-BUTINACA is C21H22BrN3O.

Pharmacology

As a synthetic cannabinoid, ADB-5'Br-BUTINACA acts as a potent agonist for the CB1 receptor. This receptor is primarily found in the brain and is responsible for the psychoactive effects of cannabinoids. The exact mechanism of action of ADB-5'Br-BUTINACA is not fully understood, but it is believed to mimic the effects of naturally occurring cannabinoids such as THC by binding to and activating the CB1 receptor.

Effects

The effects of ADB-5'Br-BUTINACA can vary greatly depending on the dose and the individual's tolerance to cannabinoids. Common effects include euphoria, relaxation, altered perception, and increased appetite. However, ADB-5'Br-BUTINACA can also cause negative effects such as anxiety, paranoia, and in some cases, psychosis.

Legal Status

The legal status of ADB-5'Br-BUTINACA varies by country. In many countries, including the United States, it is classified as a Schedule I controlled substance, making it illegal to manufacture, distribute, or possess.

See Also

• Synthetic cannabinoids
• Designer drugs
• Cannabinoid receptor